Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features

PURPOSE: Cytoreductive therapy is beneficial in patients with essential thrombocythemia (ET) at high risk of thrombosis. However, its value in those lacking high-risk features remains unknown. This open-label, randomized trial compared hydroxycarbamide plus aspirin with aspirin alone in patients wit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Godfrey, Anna L., Campbell, Peter J., MacLean, Cathy, Buck, Georgina, Cook, Julia, Temple, Julie, Wilkins, Bridget S., Wheatley, Keith, Nangalia, Jyoti, Grinfeld, Jacob, McMullin, Mary Frances, Forsyth, Cecily, Kiladjian, Jean-Jacques, Green, Anthony R., Harrison, Claire N.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2018
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6269131/
https://ncbi.nlm.nih.gov/pubmed/30153096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2018.78.8414
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados